ConductScience.org, home

Paper21394633

Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.

Newman-Tancredi A and 1 other. Psychopharmacology (Berl), 2011. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Papers, record 21394633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21394633

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
2011
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
4.54
iCite
Revised in PubMed
2021-10-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Newman-Tancredi AAdrian
2Kleven MSMark S

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Dopamine D2 Receptor AntagonistsMajor topic
Serotonin 5-HT1 Receptor AgonistsMajor topic
Animals
Basal Ganglia Diseases
Humans
Models, Biological
Protein Binding
Receptors, Dopamine D2
Schizophrenia

Source PubMed

Download CSV of topics

References211

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116554049Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.Eur J Pharmacol2006https://conductscience.org/library/papers/16554049PubMed
217391821Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry2007https://conductscience.org/library/papers/17391821PubMed
319909227Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?Curr Pharm Des2010https://conductscience.org/library/papers/19909227PubMed
42884687Provocative tests with psychostimulant drugs in schizophrenia.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2884687PubMed
514507979Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.J Neurosci2003https://conductscience.org/library/papers/14507979PubMed
615900318N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.Neuropsychopharmacology2005https://conductscience.org/library/papers/15900318PubMed
716237386Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women.Neuropsychopharmacology2006https://conductscience.org/library/papers/16237386PubMed
818621404Serotonergic approaches in the development of novel antipsychotics.Neuropharmacology2008https://conductscience.org/library/papers/18621404PubMed
919464324Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.Behav Brain Res2009https://conductscience.org/library/papers/19464324PubMed
1018772034Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.Prog Brain Res2008https://conductscience.org/library/papers/18772034PubMed
1120571978Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression.Curr Opin Investig Drugs2010https://conductscience.org/library/papers/20571978PubMed
1216326078Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable.Eur Neuropsychopharmacol2006https://conductscience.org/library/papers/16326078PubMed
1312589516Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12589516PubMed
1417242925Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.Psychopharmacology (Berl)2007https://conductscience.org/library/papers/17242925PubMed
1514972078Do we still believe in the dopamine hypothesis? New data bring new evidence.Int J Neuropsychopharmacol2004https://conductscience.org/library/papers/14972078PubMed
1612680740The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.J Psychopharmacol2003https://conductscience.org/library/papers/12680740PubMed
1715649104Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.Drug Saf2005https://conductscience.org/library/papers/15649104PubMed
1812955285NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12955285PubMed
199152998[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.Neurochem Int1997https://conductscience.org/library/papers/9152998PubMed
2020410873The antipsychotics olanzapine, risperidone, clozapine, and haloperidol are D2-selective ex vivo but not in vitro.Neuropsychopharmacology2010https://conductscience.org/library/papers/20410873PubMed

See all 211 referencesDownload CSV of references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
42664351The structure of the dopamine D3 receptor bound to cariprazine reveals principles for partial agonists with designed pharmacology.Sci Adv2026https://conductscience.org/library/papers/42664351PubMed
41304890Review of Autism Spectrum Disorder (ASD): Epidemiology, Aetiology, Pathology, and Pharmacological Treatment.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304890PubMed
41097070Gepirone for Major Depressive Disorder: From Pharmacokinetics to Clinical Evidence: A Narrative Review.Int J Mol Sci2025https://conductscience.org/library/papers/41097070PubMed
40064751Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.Pharmacol Rep2025https://conductscience.org/library/papers/40064751PubMed
37732133Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis.Schizophr Res Cogn2023https://conductscience.org/library/papers/37732133PubMed
37549917In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics.Int J Neuropsychopharmacol2023https://conductscience.org/library/papers/37549917PubMed
37470979Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia.CNS Drugs2023https://conductscience.org/library/papers/37470979PubMed
36813773Seasonality of brain function: role in psychiatric disorders.Transl Psychiatry2023https://conductscience.org/library/papers/36813773PubMed
36721972Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis.Int J Neuropsychopharmacol2023https://conductscience.org/library/papers/36721972PubMed
36700327Cariprazine - an Alternative Treatment for Clozapine-resistant Schizophrenia?Clin Psychopharmacol Neurosci2023https://conductscience.org/library/papers/36700327PubMed
36661568Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders.J Med Chem2023https://conductscience.org/library/papers/36661568PubMed
354347668-OH-DPAT enhances dopamine D2-induced maternal disruption in rats.J Comp Physiol A Neuroethol Sens Neural Behav Physiol2022https://conductscience.org/library/papers/35434766PubMed
35022720Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats.Int J Neuropsychopharmacol2022https://conductscience.org/library/papers/35022720PubMed
34376825Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs.Mol Psychiatry2022https://conductscience.org/library/papers/34376825PubMed
33805130Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers.Polymers (Basel)2021https://conductscience.org/library/papers/33805130PubMed
33602344Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems.J Cannabis Res2021https://conductscience.org/library/papers/33602344PubMed
33414418Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges.Transl Psychiatry2021https://conductscience.org/library/papers/33414418PubMed
32726254Current Understanding of the Neurobiology of Agitation.West J Emerg Med2020https://conductscience.org/library/papers/32726254PubMed
32215360Restless legs syndrome following the use of ziprasidone: a case report.Gen Psychiatr2020https://conductscience.org/library/papers/32215360PubMed
32209227Identification of slit3 as a locus affecting nicotine preference in zebrafish and human smoking behaviour.Elife2020https://conductscience.org/library/papers/32209227PubMed

See all 57 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HTR1A3350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene
HTR2A3356PubTator's text mininghttps://conductscience.org/library/genes/3356NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21394633

GET https://conductscience.org/api/papers/v1/21394633/references?page=2